In this supplement:
Safety and Tolerability of Topical Agents for Actinic Keratosis: A Systematic Review of Phase 3 Clinical Trials
Topical agents for actinic keratosis (AK), along with cryotherapy and phototherapy, are the most commonly used therapies for areas of skin with multiple AKs. Multiple options for the topical treatment of AK exist; newer therapies aim to balance efficacy with an acceptable safety and tolerability profile for the patient.
Read full article here.
The Importance of Local Tolerability and Duration of Therapy in Topical Actinic Keratosis Treatment
Actinic keratoses (AK) are among the most common dermatologic presentations, with estimates suggesting that they account for approximately 15 percent of dermatologic diagnoses in the US.1 Incidence of AK increases with advanced age and chronic exposure to UV radiation,2 suggesting that dermatologistswill continue to see a continuing high incidence of AKs with the ongoing graying of America.
Read full article here.
Safety and Tolerability of Topical Agents for Actinic Keratosis: A Systematic Review of Phase 3 Clinical Trials
Topical agents for actinic keratosis (AK), along with cryotherapy and phototherapy, are the most commonly used therapies for areas of skin with multiple AKs. Multiple options for the topical treatment of AK exist; newer therapies aim to balance efficacy with an acceptable safety and tolerability profile for the patient.
Read full article here.
The Importance of Local Tolerability and Duration of Therapy in Topical Actinic Keratosis Treatment
Actinic keratoses (AK) are among the most common dermatologic presentations, with estimates suggesting that they account for approximately 15 percent of dermatologic diagnoses in the US.1 Incidence of AK increases with advanced age and chronic exposure to UV radiation,2 suggesting that dermatologistswill continue to see a continuing high incidence of AKs with the ongoing graying of America.
Read full article here.
